期刊文献+

家兔血浆中甲硝唑的血药浓度测定

DETERMINATION OF METRONIDAZOLE DRUG BLOOD CONCENTRATION IN RABBIT′S PLASM
下载PDF
导出
摘要 采用家兔血浆中甲硝唑的含量测定方法,研究该药不同剂型的药物动力学特点.方法:采用紫外分光光度法测定甲硝唑的血药浓度.结果:标准曲线为C=16.679A+0.7003,线性范围为1.62μg/mL~22.68μg/mL,r=0.9997,方法检出限为1.52μg/mL,回收率为102.86%,RSD为1.2%.结论:该方法准确、精密,适用于甲硝唑在兔体内药物动力学研究. Objective: To develop a method for quantitative determination of metronidazole in plasma of rabbits and to study its pharmacokinetics. Methods: to determinate quantitation of metronidazole in rabbit plasma by UV. Results: The standard curve is C=16.679A+0.7003. The linear range was 1.62μg/mL~22.68μg/mL and the correlation coefficient was 0.9997.The recovery of method was 102.86%, RSD was 1.2%;The lower limit of quantification was 1.52μg/mL.Conclusion: The method is accurate, precise and is appropriate for the determination of metronidazole.
出处 《陕西科技大学学报(自然科学版)》 2005年第1期22-24,共3页 Journal of Shaanxi University of Science & Technology
关键词 甲硝唑 紫外分光光度法 含量测定 metronidazole ultraviolet spectrophomete(UV) quantative determination
  • 相关文献

参考文献4

二级参考文献10

  • 1钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 2Achari R, Laddu A. Terazosin: A new alpha adrenoceptor blocking drug. J Clin Pharmacol , 1992,32:520. 被引量:1
  • 3Patterson SE. Rapid and sensitive analysis of terazosin in plasma,peritoneal dialysis solution, and urine using high - performance liquid chromatography with fluorescence detection. J Chromatogr,1984,311:206. 被引量:1
  • 4Sekhar EC, Rao TR, Sekhar KR, et al. Determination of terazosin in human plasma using high - performance liquid chromatography with fluorescence detection. J Chromatogr B, 1998,710 : 137. 被引量:1
  • 5Cheah PY,Yuen KH, Liong ML. Improved high -performance liquid chromatographic analysis of terazosin in human plasma. J Chromatogr B,2000,745:439. 被引量:1
  • 6Zavitsanos AP, Alebic - Kolbah. Enantioselective determination of terazosin in human plasma by normal phase high - performance liquid chromatography - electrospray mass spectrometry. J Chromatogr A, 1998,794:45. 被引量:1
  • 7Karnes HT, March C. Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis. Pharm Res, 1993,10 (10) :1420. 被引量:1
  • 8Titmarsh S, Monk JP. Terazosin : A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension. Drugs, 1987,33:461. 被引量:1
  • 9Mcneil J J, Drummer OH, Raymond K,et al. The influence of food on the oral bioavailability of terazosin. Br J Clin Pharmacol, 1991,32:775. 被引量:1
  • 10Patterson SE. Terazosin kinetics after oral and intravenous doses. Clin Pharmacol Ther,1985,38(4) :423. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部